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SUMMARY. Substrate-dependent inhibition of CYP3A4 might influence the extrapolation of drug interac-
tions from the in vitro to in vivo situation. The aim of the present study is to investigate reversible and
time-dependent inhibition of CYP3A4-mediated nifedipine oxidation by noscapine. Furthermore, in vitro-
in vivo extrapolation (IVIVE) was performed using in vitro parameters. The results showed that CYP3A4-
mediated nifedipine oxidation activity was strongly inhibited with an IC50 of 25.7 ± 5.4 μM. Kinetic analy-
sis showed that inhibition of CYP3A4-mediated nifedipine oxidation by noscapine was best fit to a non-
competitive manner with Ki value of 10.9 μM. IC50 shift experiment showed that IC50 was significantly
decreased from 25.7 ± 5.4 μM to 0.34 ± 0.07 μM after pre-incubation with noscapine for 30 min, which in-
dicated that time-dependent inhibition existed for inhibition of CYP3A4 by noscapine. The AUC of (R)-
warfarin was predicted to increase by 0.5 % using Cmax or 0.2 % using unbound Cmax with reversible in-
hibition prediction equation, while the AUC of (R)-warfarin was estimated to increase by 23.1 % using
Cmax or 10.4 % using unbound Cmax with TDI prediction equation. Inhibition of CYP3A4 by noscapine
showed substrate-dependent inhibition behaviour. However, the results obtained from IVIVE are very
similar using testosterone or nifedipine as probe substrates.
